Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 3.67% vs 2.78% in Sep 2024

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is 7.54% vs 25.56% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 5.46% vs 28.63% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is -20.00% vs -16.67% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

324.92

165.48

159.44

96.35%

Other Operating Income

0.00

Total Operating income

324.92

165.48

159.44

96.35%

Raw Material Cost

78.13

108.42

-30.29

-27.94%

Purchase of Finished goods

10.64

0.00

10.64

(Increase) / Decrease In Stocks

-20.37

-50.56

30.19

59.71%

Employee Cost

53.88

18.55

35.33

190.46%

Power Cost

0.00

Manufacturing Expenses

0.00

0.01

-0.01

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

82.37

34.11

48.26

141.48%

Total Expenditure (Excl Depreciation)

204.65

110.53

94.12

85.15%

Operating Profit (PBDIT) excl Other Income

120.27

54.95

65.32

118.87%

Other Income

4.95

24.27

-19.32

-79.60%

Operating Profit (PBDIT)

125.22

79.22

46.00

58.07%

Interest

0.12

4.63

-4.51

-97.41%

Exceptional Items

0.00

Gross Profit (PBDT)

125.10

74.59

50.51

67.72%

Depreciation

6.08

5.87

0.21

3.58%

Profit Before Tax

119.02

68.73

50.29

73.17%

Tax

30.48

16.59

13.89

83.73%

Provisions and contingencies

0.00

Profit After Tax

88.54

52.14

36.40

69.81%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

88.54

52.14

36.40

69.81%

Equity Capital

16.60

34.69

-18.09

-52.15%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

53.34

3.01

50.33

1,672.09%

Diluted Earnings per share

53.34

3.01

50.33

1,672.09%

Operating Profit Margin (Excl OI)

37.02%

33.21%

0.00

3.81%

Gross Profit Margin

38.50%

45.07%

0.00

-6.57%

PAT Margin

27.25%

31.51%

0.00

-4.26%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 324.92 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -4.08% vs 8.92% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 3.67% vs 2.78% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 88.54 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 33.79% vs 8.17% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 7.54% vs 25.56% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 120.27 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 33.13% vs 11.64% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 5.46% vs 28.63% in Sep 2024

Quarterly - Interest

Interest 0.12 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -7.69% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -20.00% vs -16.67% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 37.02%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024